US Stock MarketDetailed Quotes
UBER Uber Technologies
- 59.930
- -1.480-2.41%
Close Dec 13 16:00 ET
- 60.190
- +0.260+0.43%
Post 20:01 ET
126.20BMarket Cap29.52P/E (TTM)
62.260High59.740Low47.33MVolume61.860Open61.410Pre Close2.87BTurnover2.26%Turnover Ratio68.89P/E (Static)2.11BShares87.00052wk High8.54P/B125.60BFloat Cap54.84052wk Low--Dividend TTM2.10BShs Float87.000Historical High--Div YieldTTM4.10%Amplitude13.710Historical Low60.724Avg Price1Lot Size
Uber Technologies Stock Forum
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
4
1
1
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...
+2
1
$Uber Technologies (UBER.US)$ robotaxi will kill Uber
1
1
$Uber Technologies (UBER.US)$ how can this stock get any lower?!
1
1
$Uber Technologies (UBER.US)$ bankruptcy
1
1
$Uber Technologies (UBER.US)$ and Adobe, beat the estimates but no bright future? ugh
1
2
$Uber Technologies (UBER.US)$ the laughing stock of the stock market
$Uber Technologies (UBER.US)$ this stock is donezo. tesla and waymo will eat all of its demand up. best short target
No comment yet
Business Data
Active users
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.